Pasar al contenido principal

PERSONALIZACION DEL USO DE LECHE MATERNA DE BANCO PARA LA PROMOCION DEL DESARROLLO DEL MICROBIOMA INTESTINAL NEONATAL

PID2021-125337OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Gut Microbiota in Infants: Focus on Bifidobacterium

  • Solís, Gonzalo
  • Gueimonde Fernández, Miguel
A long time has passed since the initial pioneering works were carried out on the composition of infant microbiota by Thedore Escherich (1857–1911) and Ernst Moro (1874–1951), and since the observations of Henry Tissier (1866–1916) which linked “Bacillus bifidus” to the health of babies [...], This work has been funded by Grants AGL2017-83653R and PID2021-125337OB-I00 from MCIN/AEI/10.13039/50110001103/FEDER/UE., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Old Folks, Bad Boon: Antimicrobial Resistance in the Infant Gut Microbiome

  • Saturio López, Silvia
  • Rey-Mariño, Alejandra
  • Samarra, Anna
  • Collado, María Carmen
  • Suárez, Marta
  • Mantecón, Laura
  • Solís, Gonzalo
  • Gueimonde Fernández, Miguel
  • Arboleya, Silvia
The development of the intestinal microbiome in the neonate starts, mainly, at birth, when the infant receives its founding microbial inoculum from the mother. This microbiome contains genes conferring resistance to antibiotics since these are found in some of the microorganisms present in the intestine. Similarly to microbiota composition, the possession of antibiotic resistance genes is affected by different perinatal factors. Moreover, antibiotics are the most used drugs in early life, and the use of antibiotics in pediatrics covers a wide variety of possibilities and treatment options. The disruption in the early microbiota caused by antibiotics may be of great relevance, not just because it may limit colonization by beneficial microorganisms and increase that of potential pathogens, but also because it may increase the levels of antibiotic resistance genes. The increase in antibiotic-resistant microorganisms is one of the major public health threats that humanity has to face and, therefore, understanding the factors that determine the development of the resistome in early life is of relevance. Recent advancements in sequencing technologies have enabled the study of the microbiota and the resistome at unprecedent levels. These aspects are discussed in this review as well as some potential interventions aimed at reducing the possession of resistance genes., This research was funded by MCIN/AEI/10.13039/501100011033/ and FEDER “Una forma de hacer Europa”, grant number PID2021-125337OB-I00, and Generalitat Valenciana (GVA) through the PROMETEO grant, “NeoHealth project PROMETEO 2020/012”. S.A. was the recipient of a postdoctoral contract; S.S. was a recipient of a predoctoral contract awarded by the Biosanitary Research Foundation in Asturias (FINBA, Spain); and A.S. was a recipient of a predoctoral Generalitat Valenciana–European Social Fund (ACIF/2021) grant. The authors also acknowledge the support of the Institute of Agrochemistry and Food Technology (IATA-CSIC) and the Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

2-Fucosyllactose Metabolism by Bifidobacteria Promotes Lactobacilli Growth in Co-Culture

  • Nogacka, Alicja
  • Cuesta Suárez, Isabel
  • Gueimonde Fernández, Miguel
  • González de los Reyes-Gavilán, Clara
Breastfeeding is recognized as the gold standard in infant nutrition, not only because of breastmilk’s intrinsic nutritional benefits but also due to the high content of different bioactive components such as 2-fucosyllactose (2′FL) in the mother’s milk. It promotes the growth of its two major consumers, Bifidobacterium longum ssp. infantis and Bifidobacterium bifidum, but the effect on other intestinal microorganisms of infant microbiota remains incompletely understood. pH-uncontrolled fecal cultures from infants donors identified as “fast 2′FL -degrader” microbiota phenotype were used for the isolation of 2′FL-associated microorganisms. The use of specific selective agents allowed the successful isolation of B. bifidum IPLA20048 and of Lactobacillus gasseri IPLA20136. The characterization of 2′FL consumption and its moieties has revealed more pronounced growth, pH drop, and lactic acid production after 2′FL consumption when both microorganisms were grown together. The results point to an association between B. bifidum IPLA20048 and L. gasseri IPLA20136 in which L. gasseri is able to use the galactose from the lactose moiety after the hydrolysis of 2′FL by B. bifidum. The additional screening of two groups of bifidobacteria (n = 38), fast and slow degraders of 2′FL, in co-culture with lactobacilli confirmed a potential cross-feeding mechanism based on degradation products released from bifidobacterial 2′FL break-down. Our work suggests that this phenomenon may be widespread among lactobacilli and bifidobacteria in the infant gut. More investigation is needed to decipher how the ability to degrade 2′FL and other human milk oligosaccharides could influence the microbiota establishment in neonates and the evolution of the microbiota in adult life., This work has been funded by Grants AGL2017-83653R and PID2021-125337OB-I00 from MCIN/AEI/10.13039/50110001103/FEDER/UE and project AYUD/2021/50981 from the Principality of Asturias to support the activity of research groups., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Personalized Nutrition with Banked Human Milk for Early Gut Microbiota Development: In Pursuit of the Perfect Match

  • Hick, Emilia
  • Suárez, Marta
  • Rey-Mariño, Alejandra
  • Mantecón, Laura
  • Fernández, Nuria
  • Solís, Gonzalo
  • Gueimonde Fernández, Miguel
  • Arboleya, Silvia
The correct initial colonization and establishment of the gut microbiota during the early stages of life is a key step, with long-lasting consequences throughout the entire lifespan of the individual. This process is affected by several perinatal factors; among them, feeding mode is known to have a critical role. Breastfeeding is the optimal nutrition for neonates; however, it is not always possible, especially in cases of prematurity or early pathology. In such cases, most commonly babies are fed with infant formulas in spite of the official nutritional and health international organizations’ recommendation on the use of donated human milk through milk banks for these cases. However, donated human milk still does not totally match maternal milk in terms of infant growth and gut microbiota development. The present review summarizes the practices of milk banks and hospitals regarding donated human milk, its safety and quality, and the health outcomes in infants fed with donated human milk. Additionally, we explore different alternatives to customize pasteurized donated human milk with the aim of finding the perfect match between each baby and banked milk for promoting the establishment of a beneficial gut microbiota from the early stages of life., This research was funded by Project PID2021-125337OB-I00 from MCIN/AEI/10.13039/50110001103/FEDER/UE. E.H. was a recipient of a predoctoral FPI contract from MCIN/AEI/10.13039/501100011033/FSE+ (Ref. PRE2022-101782)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impacts of Different Perinatal Factors on Faecal Immune Compounds in Infants: Determination of Normal Values

  • Suárez, Marta
  • Solís, Gonzalo
  • Mantecón, Laura
  • Gueimonde Fernández, Miguel
  • Arboleya, Silvia
The gut microbiota is a key and primary stimulus for the development of a host’s immune system. The early establishment of the gut microbiota is affected by several perinatal factors but little is known about their influence on shaping normal immune development and, consequently, on the programming of future health. The analysis of different immune compounds is well-documented in serum samples; however, their presence in faecal samples has not been studied, and this information could be valuable in early life. In this context, the authors of this study aimed to both describe the immunological faecal profile of a cohort of one-month-old infants and describe the impact of different perinatal factors, exploring possible associations between immune compounds and gut microbiota in faecal samples. Clear differences in immune profile were observed between full-term and premature infants. Breastfeeding increases IgG2, IgG4, and IgA; in addition, male babies showed some increased Igs, among other observations. Overall, the findings of this study reinforce the hypothesis that microorganisms and immune compounds interact with each other in the early neonatal gut and that understanding these interactions in depth will help us comprehend the influence of the gut microbiota on short- and long-term infant health outcomes, This research was funded by Project PID2021-125337OB-I00 from MCIN/AEI/10.13039/50110001103/FEDER/UE., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Comparative study of the oligosaccharide profile in goat, bovine, sheep, and human milk whey

  • Urrutia-Baca, Víctor Hugo
  • Álvarez-Buylla, Jorge R.
  • Gueimonde Fernández, Miguel
  • Chuck-Hernández, Cristina
  • Ruas-Madiedo, Patricia
  • González-Iglesias, Héctor
Milk oligosaccharides are high added value compounds that could be obtained by exploiting cheese whey, a byproduct of dairy industry. The objective was to compare the abundance and diversity of oligosaccharides in whey samples from domestic animals and humans. During fresh cheese making, whey samples were collected and analyzed by untargeted and targeted small molecule analysis using high-resolution mass-spectrometry. A great similarity in the metabolite profile between goat and sheep was observed. Up to 11 oligosaccharides were observed in the sheep whey from those typically found in humans. The concentration of 2'-Fucosyllactose (0.136 ± 0.055 g/L) and 3-Fucosyllactose (0.079 ± 0.009 g/L) were significantly higher (p-value <0.01) in sheep whey, while the concentration of 3'-Sialyllactose (0.826 ± 0.638 g/L) was higher in goat whey. No significant differences were observed between goat and sheep whey for the other oligosaccharides (p-value >0.05). Therefore, sheep and goat whey could become an important source of oligosaccharides through their revalorization., The authors thank the Instituto de Productos Lácteos de Asturias (IPLA-CSIC), its Metabolomics facility (EQC2018-004633-P), the grant PID2021-127362OB-I00, and the BAMBI project (PID2021-125337OB.I00), all funded by MCIN/AEI/ 10.13039/501100011033 and by ERDF A way of making Europe, and the Healthy Food Unit (HFU) of the Institute for Obesity Research (IOR), Tecnológico de Monterrey for supporting the developing of this study. The present study was funded by the Bilateral Tecnológico de Monterrey- Consejo Superior de Investigaciones Científicas 2022 grant with reference BILTEC-22007. The authors acknowledge José María Mata for his technical support., Peer reviewed